The author is at the Emory Vaccine Center and Yerkes National Primate Research Center, 954 Gatewood Drive, Emory University, Atlanta, Georgia, 30329 USA. hrobins@rmy.emory.edu
Vaccines using DNA for priming and recombinant modified vaccinia Ankara virus (MVA) for boosting have shown great promise in preclinical models. Now, this novel protocol appears effective in humans (pages 729−735).